Semaglutide vs Sitagliptin

Clinical trial NCT05195944 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05195944
Sponsor: University Health Network, Toronto
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Liver Transplant; Complications Diabetes Mellitus NASH - Nonalcoholic Steatohepatitis NAFLD

Start date: 2022-10-26
Primary completion: 2026-12-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.